Welcome to our dedicated page for CURALEAF HLDGS news (Ticker: $CURLF), a resource for investors and traders seeking the latest updates and insights on CURALEAF HLDGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CURALEAF HLDGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CURALEAF HLDGS's position in the market.
Curaleaf reported first quarter 2024 revenue of $339 million, a 2% year-over-year increase, with an adjusted gross margin of 48%. Adjusted EBITDA was $77 million, representing 23% of revenue. The company ended the quarter with $105 million in cash and generated $46 million in operating cash flow and $33 million in free cash flow. Key highlights include the acquisition of Northern Green Canada, expanding market presence in Europe, and successful brand expansion in the U.S..